Unilateral MRgFUS thalamotomy leads to significant, sustained improvements in quality of life and NMS in patients with refractory ET with most patients reporting a marked clinical benefit at 1 year.
Gea et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: